CCN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Crit Care Nurse 1996 Jul; 16(3): 53-58
This Article
Right arrow Respond to This Article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dirkes, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dirkes, S
Critical Care Nurse, Vol 16, Issue 3, 53-58
Copyright © 1996 by American Association of Critical Care Nurses

Articles

Liquid ventilation: new frontiers in the treatment of ARDS

S Dirkes

At our institution, PLV continues to be used as an investigational therapy for patients with ARDS who meet the protocol criteria. Since this is the beginning of the first nonneonatal clinical trial of PLV, results of this therapy are not yet available. Adverse effects on hemodynamic parameters have not been documented in the current literature for patients treated with liquid ventilation. In addition, further clinical studies using PLV therapy will be necessary to determine whether it will significantly change the morbidity and mortality of ARDS in infants or adults. Other questions to be answered include the cost-effectiveness of using this therapy for patients with ARDS, as well as what type of program will be required to carry out this therapy. It is hoped that this type of ventilatory therapy will offer an effective, simple method of treatment for patients with ARDS in the future.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Association of Critical-Care Nurses.